A-Ret vs Retino-A vs Tretin: Indian Tretinoin Generics Compared

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

A-Ret vs Retino-A vs Tretin: Indian Tretinoin Generics Compared

Quick Answer: A-Ret (Menarini), Retino-A (Johnson & Johnson Janssen India), and Tretin (Cipla) are three of the most-used WHO-GMP tretinoin generics worldwide. All three deliver the same active molecule at the same labelled strengths (0.025% and 0.05%), but they differ in vehicle (gel vs cream vs micro-gel), packaging (aluminium tube vs lacquered tube), price, and global availability. Retino-A is the longest-running and most stocked; A-Ret is the most affordable; Tretin is the cleanest cream formulation. This guide compares them head-to-head so you can pick the right one for your skin and budget.

Why Brand Choice Matters Even When the Molecule Is Identical

Tretinoin (all-trans retinoic acid) is a single molecule. Every regulator-approved generic tretinoin contains the same active ingredient at the labelled concentration. But topical generics are not just the active ingredient — they’re the active dissolved into a vehicle (cream, gel, micro-gel) that determines how the drug penetrates the stratum corneum, how irritating it feels, and how cosmetically pleasant the routine is.

For tretinoin specifically, vehicle differences produce measurable clinical differences:

• Gel vehicles penetrate faster and feel lighter; they tend to be more irritating on dry/sensitive skin but better suited to oily skin
• Cream vehicles include emollient excipients that buffer irritation; they’re slower to absorb but kinder to dry skin
• Micro-gel / micro-sphere vehicles use polymer microspheres to slow drug release; the irritation profile sits between gel and cream

The right brand for you depends on skin type, tolerance, and whether you prefer to buffer (see our tretinoin sandwich method guide) or apply neat.

Head-to-Head Comparison

The Three Brands in Detail

Retino-A: The Original Indian Generic

Retino-A has been manufactured by Janssen India (a Johnson & Johnson subsidiary) since the late 1980s — making it the longest-running tretinoin generic in the Indian market. The classic Retino-A is a cream containing 0.025% or 0.05% tretinoin in a vehicle of stearic acid, polyoxyl 40 stearate, isopropyl myristate, and BHT. The cream is rich and emollient — beginners and dry-skinned users typically find it more tolerable than gel formulations.

Janssen also markets Retino-A Micro Gel at 0.04% and 0.1% — a different formulation that uses microsphere technology to slow tretinoin release. This is the closest WHO-GMP analogue to the US-branded Retin-A Micro and the recommended choice if you want lower-irritation 0.1% strength.

Other Retino-A products in the Indian market: Retino-A Cream (classic 0.025% and 0.05%), Retino-AC Gel (tretinoin + clindamycin combination for inflammatory acne).

A-Ret: The Affordable Gel Option

A-Ret was originally a Cipla brand introduced in 1996 and transferred to Menarini India in 2018. It’s a tretinoin gel — typically less expensive than Retino-A and available at 0.025%, 0.05%, and 0.1% strengths. The gel vehicle is hydroalcoholic, which means it absorbs quickly and feels cosmetically light but increases irritation potential.

For oily skin or acne-prone users who want the antiproliferative effect of tretinoin without the heaviness of cream, A-Ret is the workhorse choice. The 0.1% strength is particularly cost-effective compared to brand-name 0.1% formulations. For an in-depth single-brand guide see our A-Ret Gel buying guide.

Tretin: Cipla’s Cream Formulation

Tretin is Cipla’s tretinoin cream brand, distinct from the gel-only A-Ret. Available at 0.025% and 0.05% strengths in a 20 g tube. The cream uses a standard hydrophilic vehicle and sits between Retino-A (richer cream) and A-Ret (lighter gel) in feel.

Tretin tends to be the cheapest cream option, making it a popular starter choice for beginners who can’t tolerate gel formulations but don’t want to pay the Retino-A premium. Tretin Cream is widely available; Cipla also markets Tretinex Cream and Tretiheal Cream at the same strengths under different sub-brand naming.

Which Brand for Which User?

Pick Retino-A if: you have dry, sensitive, or mature skin · you’re focused on anti-ageing (fine lines, photodamage) · you’re willing to pay a premium for the Janssen/J&J brand · you want the Retino-A Micro Gel for lower-irritation 0.1% strength

Pick A-Ret if: you have oily or acne-prone skin · you want fast absorption with no residue · you want the most cost-effective WHO-GMP tretinoin · you need 0.1% strength at a lower price point

Pick Tretin if: you’re a beginner who wants a cream but doesn’t need premium brand · you have normal to combination skin · you want a balanced cream texture without the Retino-A price · you’re starting at 0.025% and titrating up

Strength Selection: Read Before Buying

Before picking a brand, pick a strength. The standard ladder is:

• 0.025% — beginner-friendly; reduces irritation, slower visible results (12–16 weeks for acne, 24+ weeks for photoaging)
• 0.05% — most-prescribed strength for adults; balanced efficacy and tolerability; full effect by 16–24 weeks
• 0.1% — maximum-strength; reserved for users who’ve titrated up from lower strengths; most efficacy data exists at this concentration

See our tretinoin strengths guide for the full clinical comparison and starter protocol.

Vehicle Effect on Tolerability

Research spotlight: Multiple randomised tolerability studies have compared tretinoin gel vs cream vehicles. Verschoore et al (1991) found tretinoin 0.025% cream produced significantly less erythema, scaling, and burning than 0.025% gel at the same strength — confirming the vehicle (not the active) drives much of the side-effect profile. For first-time users, starting with cream at 0.025% is associated with significantly lower discontinuation rates in the first 8 weeks.

Storage and Shelf Life

All three brands ship in aluminium tubes that protect tretinoin from light degradation. Stored at room temperature (15–30 °C), unopened tubes are stable for 24–36 months from manufacture date. Once opened:

• Gel formulations (A-Ret): use within 6 months — alcohol evaporation degrades vehicle properties faster
• Cream formulations (Retino-A, Tretin): use within 12 months once opened
• Micro-gel formulations: use within 9 months once opened

Always close the tube tightly after each use; tretinoin is photolabile and reactive with oxygen.

Real-World Application Notes

Pea-Sized Quantity Rule

All three brands deliver tretinoin at a similar molar dose per unit area when applied as a pea-sized amount spread across the full face. Using more does not produce faster or stronger results — it just increases irritation. A 20 g tube applied as a pea-sized amount nightly lasts approximately 3–4 months.

Sunscreen Is Non-Negotiable

Tretinoin from any brand thins the stratum corneum and dramatically increases UV sensitivity. SPF 50 broad-spectrum sunscreen every morning is required during topical retinoid use. See our tretinoin and sun exposure guide for the photosensitivity timeline and protocol.

Buffering Strategy

If you start with A-Ret 0.05% and experience excessive irritation, switch to one of:

• A-Ret 0.025% (lower strength, same gel vehicle)
• Tretin 0.05% (same strength, gentler cream vehicle)
• Retino-A Micro Gel 0.04% (slow-release, lower peak concentration)

The sandwich method (moisturiser → tretinoin → moisturiser) reduces irritation across all three brands without losing meaningful efficacy.

What About Adapalene as an Alternative?

Adapalene is a third-generation retinoid that’s less irritating than tretinoin but slightly less effective for anti-ageing. Available OTC in the US (Differin) but commonly used as a beginner alternative. See our full tretinoin vs adapalene comparison.

Frequently Asked Questions

Are A-Ret, Retino-A, and Tretin the same drug?

Yes — all three contain tretinoin (all-trans retinoic acid) at the labelled concentration. The active ingredient is identical. They differ in the vehicle (gel vs cream vs micro-gel), manufacturer, and price.

Can I switch between them mid-course?

Yes — switching brands at the same strength is safe and common. Many users start with cream (Tretin or Retino-A) at 0.025% and switch to gel (A-Ret) at 0.05% once they’ve built tolerance.

Which has the fewest side effects?

Retino-A cream (classic formulation) is generally the gentlest for beginners due to its rich emollient base. Retino-A Micro Gel offers slow-release benefits at higher strengths. A-Ret gel is the most irritating in head-to-head comparisons because of the hydroalcoholic vehicle.

Are they all WHO-GMP certified?

Yes. Janssen India (Retino-A), Cipla (Tretin), and Menarini India (A-Ret) all hold WHO Good Manufacturing Practice prequalification. These are the same manufacturers that supply Indian government tender pharmaceuticals and export to regulated markets worldwide.

Why does the same strength have different prices?

Brand premium. Retino-A carries the Johnson & Johnson brand name and tends to be priced at a premium. A-Ret and Tretin are budget-positioned Cipla / Menarini brands. All three contain the same active ingredient under WHO-GMP standards.

Can I get the same results from a cheaper brand?

Yes — if your skin type matches the vehicle. The active molecule is identical. The right question isn’t “which is best” but “which vehicle suits my skin type at my budget.”

Is there a generic equivalent to US-branded Retin-A Micro?

Retino-A Micro Gel by Janssen India is the closest WHO-GMP equivalent — same microsphere release technology, same Janssen-owned brand family, lower price point.

Medical Disclaimer: Topical tretinoin is photosensitising and requires diligent daily SPF use. Tretinoin is teratogenic and should not be used during pregnancy or by those planning pregnancy. Always work with a qualified dermatologist for individual skin assessment and treatment plan.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.